Abano Healthcare Group Limited provided earnings guidance for the year ending May 31, 2014. For the year, the company expects reported revenue to be between $209.8 million to $211.8 million with earnings before interest, tax, depreciation and amortization (EBITDA) to be between $27.3 million to $28.3 million generating a net profit after tax (NPAT) between $4.5 million to $5.0 million. The company's underlying EBITDA is expected to be between $28.5 million to $29.5 million, resulting in an underlying NPAT between $5.8 million to $6.3 million.

The company expects EPS at NPAT (weighted average) of 23.1 - 25.7 cents and EPS at underlying NPAT (weighted average) of 29.8 – 32.4 cents.